Multi-target regulatory effects of rhaponticin in a rat model of hepatic fibrosis revealed by non-targeted metabolomics

Multi-target regulatory effects of rhaponticin in a rat model of hepatic fibrosis revealed by non-targeted metabolomics

IntroductionHepatic fibrosis (HF), a progressive chronic liver disease, is a serious threat to global public health. The lack of preventive and therapeutic strategies has created an urgent need for effective anti-fibrosis agents. There is growing evidence that natural products might provide safe and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Min Yang, Dihua Jiang, Longfei Huang, Tao Zhang, Wenfen Guo, Wenyan Lin, Jiali Zhao, Yunsheng Wei, Lang Peng, Yong-Jia Hao, Ying Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	hepatic fibrosis traditional Chinese medicine rhaponticin metabolomic molecular mechanism
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1505309/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Non-targeted metabolomics and network pharmacology of Taohong Siwu Decoction in hepatic fibrosis mouse model using high resolution mass spectrometry
by: Shengsheng Li, et al.
Published: (2025-06-01)

Multi-omics analysis of host-microbiome interactions in a mouse model of congenital hepatic fibrosis
by: Mengfan Jiao, et al.
Published: (2025-03-01)

Uncovering the Efficacy and Mechanism of Zhenwu Decoction for Hypothyroidism Based on Non-Targeted Metabolomics
by: Wang Y, et al.
Published: (2025-06-01)

Research advances of Chinese medicine in preventing and treating diabetic nephropathy and renal fibrosis
by: Cao Liu-yang, et al.
Published: (2021-01-01)

Acetoacetate Ameliorates Hepatic Fibrosis by Targeting Peroxisome Proliferator-Activated Receptor Gamma to Restore Lipid Droplets in Activated Hepatic Stellate Cells
by: Ya Zhou, et al.
Published: (2025-02-01)

Traditional Chinese Medicine targeting the TGF-β/Smad signaling pathway as a potential therapeutic strategy for renal fibrosis
by: Hao Jiao, et al.
Published: (2025-05-01)

Application of metabolomics in quality control of traditional Chinese medicines: a review
by: Peiran Ji, et al.
Published: (2024-11-01)

Effect of Allostatic Load on hepatic steatosis and fatty liver-associated liver fibrosis
by: Lei Zhang, et al.
Published: (2025-07-01)

Integration of Pseudotargeted Metabolomics and Microbiomics Reveals That Hugan Tablets Ameliorate NASH with Liver Fibrosis in Mice by Modulating Bile Acid Metabolism via the Gut Microbiome
by: Wenran Dong, et al.
Published: (2025-06-01)

Magnoflorine ameliorates hepatic fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway
by: Meiling Zhang, et al.
Published: (2024-11-01)

Morphological and ultrasound features of liver fibrosis in children with autoimmune hepatitis
by: V. S. Berezenko, et al.
Published: (2018-12-01)

Prognostic model of rapid hepatic fibrosis progression in men with chronic hepatitis C
by: T. I. Koval, et al.
Published: (2019-05-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Ferroptosis in pulmonary fibrosis: pathogenesis and traditional Chinese medicine-driven therapeutic approaches
by: Xudong Fan, et al.
Published: (2025-07-01)

Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999–2018
by: Shuyin Duan, et al.
Published: (2024-12-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

Unveiling the therapeutic mechanisms of Saorilao-4 decoction in pulmonary fibrosis through metabolomics and transcriptomics
by: Jiali Liu, et al.
Published: (2025-08-01)

Chondroitin Sulfate-Based Imatinib Nanoparticles Targeting Activated Hepatic Stellate Cells Against Hepatic Fibrosis
by: Xunzhi Liu, et al.
Published: (2025-03-01)

Relationship of tea consumption with hepatic steatosis and fibrosis: findings from a longitudinal RaNCD cohort
by: Shaimaa A. Qaisar, et al.
Published: (2025-03-01)

Heparan sulfate proteoglycan-mediated internalization of extracellular vesicles ameliorates liver fibrosis by targeting hepatic stellate cells
by: Rongrong Li, et al.
Published: (2022-12-01)

Fangchinoline attenuates hepatic fibrosis by regulating taurine metabolism and oxidative stress
by: Hui Yin, et al.
Published: (2025-08-01)

Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Jian Wang, et al.
Published: (2025-01-01)

Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
by: Sheng Liqin, et al.
Published: (2025-08-01)

Efficacy and metabolomic analysis of the pneumonia compound formulation against community-acquired pneumonia: an observational controlled before-after clinical trial
by: Ying Zhou, et al.
Published: (2025-03-01)

Protecting kidney function: from mechanisms to therapeutic targets and traditional Chinese medicine
by: Yilin Meng, et al.
Published: (2025-12-01)

Mass spectrometry-based metabolomic as a powerful tool to unravel the component and mechanism in TCM
by: Guang-Qin Liao, et al.
Published: (2025-05-01)

Comprehensive characterization and metabolomics to explore the role of hydrocortisone-induced yin deficiency syndrome in mice
by: Wenqi Jin, et al.
Published: (2024-12-01)

MRI findings of confluent hepatic fibrosis caused by different etiologies
by: Dan Yu, et al.
Published: (2025-07-01)

A study to assess hepatic steatosis and fibrosis in chronic hepatitis B patients with the help of non-invasive tests
by: Gaurav Singh, et al.
Published: (2025-07-01)

Enhancing liver fibrosis detection: a novel PIGR-utilizing approach in chronic hepatitis B injury assessment
by: Shanshan Chu, et al.
Published: (2025-02-01)

Assessment of hepatic fibrosis in patients with rheumatoid arthritis on long-term methotrexate therapy using transient elastography
by: Abhishek Kumar, et al.
Published: (2018-01-01)

Congenital hepatic fibrosis (a case report)
by: O. O. Popovych, et al.
Published: (2021-11-01)

Are bone morphogenetic protein-7 (BMP-7) serum levels correlated with development of hepatic fibrosis?
by: Nazlim Aktug Demir, et al.
Published: (2014-05-01)

Ethanol with thioacetamide murine model of alcoholic liver disease identifies hepatic pathways as targets for the human disease
by: Ashi Mittal, et al.
Published: (2025-01-01)

Effect of T lymphocyte on hepatic stellate cell activation in liver fibrosis
by: GONG Xiaoqian, et al.
Published: (2025-04-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Modified FIB-4 Index in Type 2 Diabetes Mellitus with Steatosis: A Non-Linear Predictive Model for Advanced Hepatic Fibrosis
by: Jonghyun Kim, et al.
Published: (2024-11-01)

Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study
by: Xiaoxian Yang, et al.
Published: (2025-03-01)

Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
by: Ye Ji Jun, et al.
Published: (2024-11-01)

MODERN METHODS FOR ESTIMATION OF LIVER FIBROSIS
by: E. V. Guschina, et al.
Published: (2015-08-01)